About Us

Meet the team

Consultant Urologists

Mr David Ross

Mr Mutie Raslan

Mr Alex Hoyle

We are a collegiate of three Urologists who together co-founded Prostate Health UK.

We are delighted to present and welcome you to The Prostate Health Clinic

MBChB, FRCS (Urol), MD, PG Dip(MedEd)

David is a Consultant Urological Surgeon with over 25 years of clinical experience and co-founder of Prostate Health UK. His clinical practice covers the breadth of general urology with a specific interest in men’s health and a subspecialty practice in kidney stones and endourology. In his practice, David is an advocate for health promotion, disease prevention and supporting patients understand and own their health. His professional portfolio includes significant leadership roles in medical education and professional standards. His academic credentials include a Postgraduate Research Doctorate in Prostate Cancer Staging and receipt of the Keith Yeates Gold Medal for outstanding academic performance.

MBChB FRCS (Urol)

My name is Mutie Raslan. I am a Consultant Urological Surgeon with over a decade of experience, specialising in prostate and bladder health. I am also co-founder of Prostate Health UK, reflecting my commitment to raising standards and awareness in men’s health. Alongside my clinical work, I have developed a particular interest in the broader aspects of men’s wellbeing, recognising that prostate health, hormonal balance, and cardiovascular risk are closely interconnected but too often assessed in isolation.

I offer a modern, comprehensive approach to men’s health, working with colleagues to deliver a thorough and personalised assessment that goes beyond a single presenting concern. This integrated service combines detailed urological evaluation with cardiovascular risk assessment and hormone profiling, providing a clear and meaningful picture of overall health and future risk. I trained in leading hospitals across the UK and completed a subspecialist Pelvic Oncology Fellowship at Oxford University Hospitals, where I gained advanced expertise in prostate and bladder cancer, including robotic surgery.

I remain actively involved in research and innovation, including the TRANSLATE trial and other initiatives focused on improving prostate cancer diagnosis and risk stratification. This enables me to offer patients access to the latest evidence-based diagnostic pathways and advanced tools such as PSMA PET imaging and the Stockholm3 test. My practice is centred on delivering high-quality, personalised care, with a strong emphasis on clarity, discretion, and ensuring that every patient feels fully informed and confident in their care.

MBChB MD FRCS (Urol) PGcert (MedED)

My name is Alex Hoyle. I am a consultant urologist in the North West of England and Co-founder of Prostate Health UK. In my medical career, I have focused my interests on urological problems disproportionally affecting men’s health. My clinical interests include the diagnosis and counselling of men suspected to have prostate or bladder cancer and I enjoy a range of surgical expertise including the use of robotic keyhole surgery and major open reconstructive surgery.

During surgical training I spent 2 years working toward a Doctorate of Medicine degree, studying the role of new drug treatments in metastatic prostate cancer. This work helped dramatically change the treatment landscape for this incurable form of the disease.

My research experience stressed to me the clear importance of early prostate cancer diagnosis. The option to offer a chance of cure or to limit the presentations of disease at an incurable stage is greatly advantageous. Ongoing uncertainty over the future of prostate cancer screening in the UK and my own family history of prostate cancer has encouraged me to support the development of a high-quality prostate cancer diagnostic service delivered by specialists in the field.

Finally, my enthusiasm for education, combined with a strong interest in preventative medicine, equips me with the skills to empower men to take control of their health. We help you identify prostate health weaknesses with the aim to help you enhance both your quality of life and longevity.

Lead Uro-Radiologists

Dr Suut is a Consultant Radiologist at Salford Royal specialising in men’s urological and prostate health. He was instrumental in the development of a prostate multiparametric MR imaging pathway, and his work was recognised with a Clinical Excellence Award.

Alongside clinical work, Dr Suut is an Honorary Senior Lecturer at the University of Manchester and a Member of the Academy of Medical Educators. He has published widely and held senior leadership roles, including Interventional Radiology Lead and Clinical Director.

Dr Pathak is a Consultant Radiologist and Clinical Director at Salford Royal Hospital. He specialises in prostate imaging as well as other aspects of urological, haematological and more general imaging.

He has a background in imaging research and is a lead radiologist for the Greater Manchester Cancer Alliance, working with partners to evaluate the role of artificial intelligence software into the prostate cancer pathway.

Lead Cardiologist

Matthew Luckie is a consultant cardiologist of over 10 years’ experience treating of wide range of patients with cardiovascular disease. He practices at both The Alexandra Hospital in Cheadle and Circle Cheshire Clinic in Northwich. His NHS practice is based at the Lancashire Cardiac Centre in Blackpool which offers tertiary cardiology and cardiac surgery services for patients across Lancashire and South Cumbria. He also acts as holds educational roles supporting the training of future consultant cardiologists across Greater Manchester.

He is passionate about prevention of cardiac disease and in ensuring patient-centred assessment and decision making when considering cardiac risk and preventative treatments.

He specialises in cardiac imaging and can offer echocardiography and cardiac CT and MR imaging where necessary to provide comprehensive assessment of any abnormalities detected on your initial clinic assessment. These investigations can also allow more detailed risk assessment and support decisions on preventative treatment when required.